Table 3. Safety summary in PACIFIC.
| Pneumonitis or radiation pneumonitis, n (%) | All patients durvalumab (n=475) | Japanese patients durvalumab (n=72) |
|---|---|---|
| Any grade | 161 (33.9) | 53 (73.6) |
| Grade 3–4 | 16 (3.4) | 4 (5.6) |
| Pneumonitis or radiation pneumonitis, n (%) | All patients durvalumab (n=475) | Japanese patients durvalumab (n=72) |
|---|---|---|
| Any grade | 161 (33.9) | 53 (73.6) |
| Grade 3–4 | 16 (3.4) | 4 (5.6) |